BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012;61:278-89. [PMID: 21672940 DOI: 10.1136/gut.2011.239145] [Cited by in Crossref: 302] [Cited by in F6Publishing: 316] [Article Influence: 27.5] [Reference Citation Analysis]
Number Citing Articles
1 Shehab-Eldeen S, Metwaly MF, Saber SM, El-Kousy SM, Badr EAE, Essa A. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular carcinoma. Dig Liver Dis 2023;55:283-90. [PMID: 35525722 DOI: 10.1016/j.dld.2022.04.015] [Reference Citation Analysis]
2 Wen Z, He K, Zhan M, Li Y, Liu F, He X, Wei Y, Zhao W, Zhang Y, Xue Y, Xia Y, Wang F, Xia Z, Xin Y, Wu Y, Duan X, Xiao J, Shen F, Feng Y, Xiang G, Lu L. Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development. Front Oncol 2022;12:904633. [PMID: 36578923 DOI: 10.3389/fonc.2022.904633] [Reference Citation Analysis]
3 Zhou X, Li J, Zheng T, Chen H, Cai C, Ye S, Gao B, Xue T. Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy. Clin Exp Metastasis 2022. [DOI: 10.1007/s10585-022-10188-1] [Reference Citation Analysis]
4 Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol 2022;15:129. [PMID: 36076302 DOI: 10.1186/s13045-022-01347-8] [Reference Citation Analysis]
5 Khan S, Zhang D, Zhang J, Hayat MK, Ren J, Nasir S, Fawad M, Bai Q. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. Front Oncol 2022;12:950374. [DOI: 10.3389/fonc.2022.950374] [Reference Citation Analysis]
6 Joshi N, Chandane Tak M, Mukherjee A. The involvement of microRNAs in HCV and HIV infection. Ther Adv Vaccines Immunother 2022;10:25151355221106104. [PMID: 35832725 DOI: 10.1177/25151355221106104] [Reference Citation Analysis]
7 Feng J, Hu S, Liu K, Sun G, Zhang Y. The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition. Cells 2022;11:1981. [DOI: 10.3390/cells11131981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Minatel BC, Cohn DE, Pewarchuk ME, Barros-filho MC, Sage AP, Stewart GL, Marshall EA, Telkar N, Martinez VD, Reis PP, Robinson WP, Lam WL. Genetic and Epigenetic Mechanisms Deregulate the CRL2pVHL Complex in Hepatocellular Carcinoma. Front Genet 2022;13:910221. [DOI: 10.3389/fgene.2022.910221] [Reference Citation Analysis]
9 Papadimitriou M, Panoutsopoulou K, Pilala K, Scorilas A, Avgeris M. Epi‐miRNAs : Modern mediators of methylation status in human cancers. WIREs RNA 2022. [DOI: 10.1002/wrna.1735] [Reference Citation Analysis]
10 Chen Z, Lin X, Wan Z, Xiao M, Ding C, Wan P, Li Q, Zheng S. High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. Genes 2022;13:876. [DOI: 10.3390/genes13050876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Nguyen TB, Do DN, Nguyen TTP, Nguyen TL, Nguyen-Thanh T, Nguyen HT. Immune-related biomarkers shared by inflammatory bowel disease and liver cancer. PLoS One 2022;17:e0267358. [PMID: 35452485 DOI: 10.1371/journal.pone.0267358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Gao W, Zhang S, Guorong L, Liu Q, Zhu A, Gui F, Zou Y, Wu Y, Luo Y, Hong Z. Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation. Cell Cycle 2022;21:340-51. [PMID: 34974812 DOI: 10.1080/15384101.2021.2020431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shi J, Wei L. Rho Kinases in Embryonic Development and Stem Cell Research. Arch Immunol Ther Exp 2022;70. [DOI: 10.1007/s00005-022-00642-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Oghbaei F, Zarezadeh R, Jafari-Gharabaghlou D, Ranjbar M, Nouri M, Fattahi A, Imakawa K. Epithelial-mesenchymal transition process during embryo implantation. Cell Tissue Res 2022. [PMID: 35024964 DOI: 10.1007/s00441-021-03574-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mortazavi D, Sohrabi B, Mosallaei M, Nariman-saleh-fam Z, Bastami M, Mansoori Y, Daraei A, Zununi Vahed S, Navid S, Saadatian Z, Jamialahmadi T, Teng Y, Sahebkar A, Ding X. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/4889807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fornari F, Gramantieri L. Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma. MicroRNA in Human Malignancies 2022. [DOI: 10.1016/b978-0-12-822287-4.00025-6] [Reference Citation Analysis]
17 Guo K, Qian K, Shi Y, Sun T, Wang Z. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. Cell Death Dis 2021;12:1097. [PMID: 34811354 DOI: 10.1038/s41419-021-04386-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
18 Liu QL, Zhang Z, Wei X, Zhou ZG. Noncoding RNAs in tumor metastasis: molecular and clinical perspectives. Cell Mol Life Sci 2021;78:6823-50. [PMID: 34499209 DOI: 10.1007/s00018-021-03929-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
19 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
20 Li M, Chen H, Xia L, Huang P. Circular RNA circSP3 promotes hepatocellular carcinoma growth by sponging microRNA-198 and upregulating cyclin-dependent kinase 4. Aging (Albany NY) 2021;13:18586-605. [PMID: 34314379 DOI: 10.18632/aging.203303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Yoshioka M, Sawada Y, Nakamura M. Diagnostic Tools and Biomarkers for Severe Drug Eruptions. Int J Mol Sci 2021;22:7527. [PMID: 34299145 DOI: 10.3390/ijms22147527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Zhang M, Xian HC, Dai L, Tang YL, Liang XH. MicroRNAs: emerging driver of cancer perineural invasion. Cell Biosci 2021;11:117. [PMID: 34187567 DOI: 10.1186/s13578-021-00630-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
23 Zhao J, Wang Y, Su H, Su L. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review. Clin Res Hepatol Gastroenterol 2021;45:101736. [PMID: 34146723 DOI: 10.1016/j.clinre.2021.101736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yang F, Wang J, Chen Z, Yang Y, Zhang W, Guo S, Yang Q. Role of microRNAs in intervertebral disc degeneration (Review). Exp Ther Med 2021;22:860. [PMID: 34178133 DOI: 10.3892/etm.2021.10292] [Reference Citation Analysis]
25 Sanuki R, Yamamura T. Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development. Int J Mol Sci 2021;22:5919. [PMID: 34072894 DOI: 10.3390/ijms22115919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY. Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications. J Hepatocell Carcinoma 2021;8:493-505. [PMID: 34095004 DOI: 10.2147/JHC.S309451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ziogas IA, Sioutas G, Mylonas KS, Tsoulfas G. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. Microrna 2020;9:25-40. [PMID: 31218966 DOI: 10.2174/2211536608666190619155406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
28 Chen E, Zhou J, Xu E, Zhang C, Liu J, Zhou J, Li M, Wu J, Yang Q. A genome-wide screen for differentially methylated long noncoding RNAs identified that lncAC007255.8 is regulated by promoter DNA methylation in Beas-2B cells malignantly transformed by NNK. Toxicol Lett 2021;346:34-46. [PMID: 33872747 DOI: 10.1016/j.toxlet.2021.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Shao N, Cheng J, Huang H, Gong X, Lu Y, Idris M, Peng X, Ong BX, Zhang Q, Xu F, Liu C. GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2. Cell Death Dis 2021;12:253. [PMID: 33692332 DOI: 10.1038/s41419-021-03550-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Zheng F, Chen J, Zhang X, Wang Z, Chen J, Lin X, Huang H, Fu W, Liang J, Wu W, Li B, Yao H, Hu H, Song E. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis. Nat Commun 2021;12:1341. [PMID: 33637716 DOI: 10.1038/s41467-021-21535-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 19.5] [Reference Citation Analysis]
31 Chen C, Shen M, Liao H, Guo Q, Fu H, Yu J, Duan Y. A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer. J Nanobiotechnology 2021;19:55. [PMID: 33632232 DOI: 10.1186/s12951-021-00800-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
33 Huang HY, Li J, Tang Y, Huang YX, Chen YG, Xie YY, Zhou ZY, Chen XY, Ding SY, Luo MF, Jin CN, Zhao LS, Xu JT, Zhou Y, Lin YC, Hong HC, Zuo HL, Hu SY, Xu PY, Li X, Huang HD. MethHC 2.0: information repository of DNA methylation and gene expression in human cancer. Nucleic Acids Res 2021;49:D1268-75. [PMID: 33270889 DOI: 10.1093/nar/gkaa1104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
34 Khan K, Safi S, Abbas A, Badshah Y, Dilshad E, Rafiq M, Zahra K, Shabbir M. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer. Biomed Res Int 2020;2020:1354381. [PMID: 33490232 DOI: 10.1155/2020/1354381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Wang Y, Soneson C, Malinowska AL, Laski A, Ghosh S, Kanitz A, Gebert LFR, Robinson MD, Hall J. MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome. Nucleic Acids Res 2021;49:25-37. [PMID: 33300035 DOI: 10.1093/nar/gkaa1117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Cai X, Yu L, Chen Z, Ye F, Ren Z, Jin P. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1. Cancer Biomark 2020;28:221-30. [PMID: 32280078 DOI: 10.3233/CBM-190490] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
37 Pea A, Jamieson NB, Braconi C. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma. Hepatology 2021;73 Suppl 1:38-48. [PMID: 32160335 DOI: 10.1002/hep.31225] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
38 Sun R, Xu Y, Zhang H, Yang Q, Wang K, Shi Y, Wang Z. Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma. Front Genet 2020;11:595242. [PMID: 33424926 DOI: 10.3389/fgene.2020.595242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Grzywa TM, Klicka K, Włodarski PK. Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers (Basel) 2020;12:E3709. [PMID: 33321819 DOI: 10.3390/cancers12123709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
40 Mohammadi C, Gholamzadeh Khoei S, Fayazi N, Mohammadi Y, Najafi R. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;157:103183. [PMID: 33310279 DOI: 10.1016/j.critrevonc.2020.103183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Hu HF, Xu WW, Zhang WX, Yan X, Li YJ, Li B, He QY. Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance. Signal Transduct Target Ther. 2020;5:271. [PMID: 33243974 DOI: 10.1038/s41392-020-00275-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
42 Cui G, Wang H, Liu W, Xing J, Song W, Zeng Z, Liu L, Wang H, Wang X, Luo H, Leng X, Shen S. Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis. Front Cell Dev Biol 2020;8:566494. [PMID: 33324633 DOI: 10.3389/fcell.2020.566494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
43 Chen J, Fu B, Bao J, Su R, Zhao H, Liu Z. Novel circular RNA 2960 contributes to secondary damage of spinal cord injury by sponging miRNA ‐124. J Comp Neurol 2021;529:1456-64. [DOI: 10.1002/cne.25030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
44 Huang Y, Li J, Chen Y, Jiang P, Wang L, Hu J. Identification of Early Recurrence Factors in Childhood and Adolescent B-Cell Acute Lymphoblastic Leukemia Based on Integrated Bioinformatics Analysis. Front Oncol 2020;10:565455. [PMID: 33134167 DOI: 10.3389/fonc.2020.565455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
45 Zhong D, Lyu X, Fu X, Xie P, Liu M, He F, Huang G. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6. Technol Cancer Res Treat 2020;19:1533033820967473. [PMID: 33073697 DOI: 10.1177/1533033820967473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Huo X, Sun H, Qian Q, Ma X, Peng P, Yu M, Zhang Y, Yang J, Cao D, Gui T, Shen K. CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity. Front Cell Dev Biol 2020;8:561804. [PMID: 33163485 DOI: 10.3389/fcell.2020.561804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
47 Das P, Taube JH. Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity. Cancers (Basel) 2020;12:E2792. [PMID: 33003334 DOI: 10.3390/cancers12102792] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
48 Hu J, Wang Z, Wang J, Jian Y, Dai J, Wang X, Xiong W. MicroRNA-182 Promotes Cell Migration by Targeting Programmed Cell Death 4 in Hepatocellular Carcinoma Cells. Onco Targets Ther 2020;13:9159-67. [PMID: 32982304 DOI: 10.2147/OTT.S258251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Majid A, Wang J, Nawaz M, Abdul S, Ayesha M, Guo C, Liu Q, Liu S, Sun MZ. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL. Front Mol Biosci 2020;7:223. [PMID: 33094104 DOI: 10.3389/fmolb.2020.00223] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
50 Luo H, Wang P, Ye H, Shi J, Dai L, Wang X, Song C, Zhang J, Li J. Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis. Front Genet 2020;11:789. [PMID: 32849795 DOI: 10.3389/fgene.2020.00789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Uray K, Major E, Lontay B. MicroRNA Regulatory Pathways in the Control of the Actin-Myosin Cytoskeleton. Cells 2020;9:E1649. [PMID: 32660059 DOI: 10.3390/cells9071649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zhou R, Joshi P, Katsushima K, Liang W, Liu W, Goldenberg NA, Dover G, Perera RJ. The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases. J Pediatr 2020;221S:S11-9. [PMID: 32482229 DOI: 10.1016/j.jpeds.2020.02.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Xie C, Zhang LZ, Chen ZL, Zhong WJ, Fang JH, Zhu Y, Xiao MH, Guo ZW, Zhao N, He X, Zhuang SM. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance. Hepatology 2020;71:1660-77. [PMID: 31509261 DOI: 10.1002/hep.30931] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 22.0] [Reference Citation Analysis]
54 Chen A, Wang J, Luo F, He Y. Role of microRNA-124-3p/Bax axis in neonatal hypoxic-ischaemic encephalopathy. Biotechnology & Biotechnological Equipment 2020;34:163-70. [DOI: 10.1080/13102818.2020.1724829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Moghadasi M, Alivand M, Fardi M, Moghadam KS, Solali S. Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications. Pathol Res Pract 2020;216:152827. [PMID: 31983567 DOI: 10.1016/j.prp.2020.152827] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
56 Liang J, Shen YC, Zhang XY, Chen C, Zhao H, Hu J. Circular RNA HIPK3 downregulation mediates hydrogen peroxide-induced cytotoxicity in human osteoblasts. Aging (Albany NY) 2020;12:1159-70. [PMID: 31955154 DOI: 10.18632/aging.102674] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
57 Qi Z, Zhang T, Song L, Fu H, Luo H, Wu J, Zhao S, Zhang T, Guo L, Jin L, Zhang H, Huang G, Ma T, Wu Y, Huang L. PRAS40 hyperexpression promotes hepatocarcinogenesis. EBioMedicine 2020;51:102604. [PMID: 31901857 DOI: 10.1016/j.ebiom.2019.102604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
58 Shahbazi R, Baradaran B, Khordadmehr M, Safaei S, Baghbanzadeh A, Jigari F, Ezzati H. Targeting ROCK signaling in health, malignant and non-malignant diseases. Immunol Lett 2020;219:15-26. [PMID: 31904392 DOI: 10.1016/j.imlet.2019.12.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
59 Seidl C, Panzitt K, Bertsch A, Brcic L, Schein S, Mack M, Leithner K, Prinz F, Olschewski H, Kornmueller K, Hrzenjak A. MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Cancer Letters 2020;469:266-76. [DOI: 10.1016/j.canlet.2019.10.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
60 Lu J, Zhou L, Wu B, Duan Y, Sun Y, Gu L, Xu D, Du C. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A. Exp Cell Res 2020;387:111752. [PMID: 31805277 DOI: 10.1016/j.yexcr.2019.111752] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
61 Sun X, Zhang X, Chen S, Fan M, Ma S, Zhai H. Myosin Heavy Chain-Associated RNA Transcripts Promotes Gastric Cancer Progression Through the miR-4529-5p/ROCK2 Axis. Dig Dis Sci 2019;64:3539-48. [PMID: 31273599 DOI: 10.1007/s10620-019-05708-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
62 Zhou Z, Lv J, Wang J, Yu H, Lu H, Yuan B, Han J, Zhou R, Zhang X, Yang X, Yang H, Lu Q, Li P. Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis. Dis Markers 2019;2019:1654780. [PMID: 31885731 DOI: 10.1155/2019/1654780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
63 Felgendreff P, Raschzok N, Kunze K, Leder A, Lippert S, Klunk S, Tautenhahn H, Hau H, Schmuck RB, Reutzel-selke A, Sauer IM, Bartels M, Morgül MH. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma. Biomarkers 2020;25:62-8. [DOI: 10.1080/1354750x.2019.1691267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Binju M, Amaya-Padilla MA, Wan G, Gunosewoyo H, Suryo Rahmanto Y, Yu Y. Therapeutic Inducers of Apoptosis in Ovarian Cancer. Cancers (Basel) 2019;11:E1786. [PMID: 31766284 DOI: 10.3390/cancers11111786] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
65 O'Brien A, Zhou T, Tan C, Alpini G, Glaser S. Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models. Cancers (Basel) 2019;11:E1652. [PMID: 31731549 DOI: 10.3390/cancers11111652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lin T, Dai Y, Guo X, Chen W, Zhao J, Cao L, Wu Z. Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis. Cancer Manag Res 2019;11:9133-43. [PMID: 31695501 DOI: 10.2147/CMAR.S222716] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
67 Zhang C, Ge S, Wang J, Jing X, Li H, Mei S, Zhang J, Liang K, Xu H, Zhang X, Zhang C. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. J Gastroenterol Hepatol 2019;34:1869-77. [PMID: 31038805 DOI: 10.1111/jgh.14694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
68 Song SK, Jung WY, Park SK, Chung CW, Park Y. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection. PLoS One. 2019;14:e0216847. [PMID: 31513595 DOI: 10.1371/journal.pone.0216847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
69 Liu Y, Li X, Zhang Y, Wang H, Rong X, Peng J, He L, Peng Y. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme. Oncogene 2019;38:7399-415. [PMID: 31427735 DOI: 10.1038/s41388-019-0952-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
70 Ai N, Li B, Li L, Li Z, Ji H, Yang G, Yin F. MicroRNA-466 inhibits cancer cell migration and invasion in hepatocellular carcinoma by indirectly mediating the downregulation of ROCK2. Exp Ther Med 2019;18:1493-9. [PMID: 31363382 DOI: 10.3892/etm.2019.7709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Mollashahi B, Aghamaleki FS, Movafagh A. The Roles of miRNAs in Medulloblastoma: A Systematic Review. J Cancer Prev 2019;24:79-90. [PMID: 31360688 DOI: 10.15430/JCP.2019.24.2.79] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
72 Horita K, Kurosaki H, Nakatake M, Ito M, Kono H, Nakamura T. Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer. Biochem Biophys Res Commun 2019;516:831-8. [PMID: 31262449 DOI: 10.1016/j.bbrc.2019.06.125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
73 Zeng B, Zhang X, Zhao J, Wei Z, Zhu H, Fu M, Zou D, Feng Y, Luo H, Lei Y. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma. BMC Cancer 2019;19:609. [PMID: 31226958 DOI: 10.1186/s12885-019-5815-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
74 Tian Z, Li Z, Zhu Y, Meng L, Liu F, Sang M, Wang G. Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC. Clin Exp Metastasis 2019;36:381-91. [PMID: 31197517 DOI: 10.1007/s10585-019-09974-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Song SK, Jung WY, Park S, Chung C, Park Y. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.. [DOI: 10.1101/625095] [Reference Citation Analysis]
76 Erstad DJ, Tanabe KK. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Ann Surg Oncol 2019;26:1474-93. [PMID: 30788629 DOI: 10.1245/s10434-019-07227-9] [Cited by in Crossref: 139] [Cited by in F6Publishing: 147] [Article Influence: 34.8] [Reference Citation Analysis]
77 Jia P, Wei G, Zhou C, Gao Q, Wu Y, Sun X, Li X. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma. Technol Cancer Res Treat 2018;17:1533034618765221. [PMID: 29618288 DOI: 10.1177/1533034618765221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
78 Cristóbal I, Sanz-Álvarez M, Luque M, Caramés C, Rojo F, García-Foncillas J. The Role of MicroRNAs in Hepatoblastoma Tumors. Cancers (Basel) 2019;11:E409. [PMID: 30909459 DOI: 10.3390/cancers11030409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
79 Tian X, Wang C, Jin X, Li M, Wang F, Huang W, Yun J, Xu R, Cai Q, Xie D. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Theranostics 2019;9:1965-79. [DOI: 10.7150/thno.30958] [Cited by in Crossref: 94] [Cited by in F6Publishing: 106] [Article Influence: 23.5] [Reference Citation Analysis]
80 Niu Y, Tang G. miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma. Oncol Lett 2019;17:5087-93. [PMID: 31105794 DOI: 10.3892/ol.2019.10144] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
81 Tang W, Lv B, Yang B, Chen Y, Yuan F, Ma L, Chen S, Zhang S, Xia J. TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway. Oncogenesis 2019;8:9. [PMID: 30683932 DOI: 10.1038/s41389-018-0115-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
82 Zhang P, Ming Y, Ye Q, Niu Y. Comprehensive circRNA expression profile during ischemic postconditioning attenuating hepatic ischemia/reperfusion injury. Sci Rep 2019;9:264. [PMID: 30670716 DOI: 10.1038/s41598-018-36443-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
83 Zhang L, Zhang T, Deng Z, Sun L. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1. Oncol Rep 2019;41:1669-77. [PMID: 30664185 DOI: 10.3892/or.2019.6971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
84 Ji H, Sang M, Liu F, Ai N, Geng C. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Pathol Res Pract 2019;215:697-704. [PMID: 30611621 DOI: 10.1016/j.prp.2018.12.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
85 Lachat C, Boyer-Guittaut M, Peixoto P, Hervouet E. Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2. Epigenomes 2018;3:1. [PMID: 34991274 DOI: 10.3390/epigenomes3010001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
86 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
87 Wang S, Zhang JH, Wang H, Yang L, Hong S, Yu B, Guo JC, Liu J, Zhu YB. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. J Cell Physiol 2019;234:11610-9. [PMID: 30480822 DOI: 10.1002/jcp.27818] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
88 Zhang Y, Liu H, An L, Li L, Wei M, Ge D, Su Z. miR‐124‐3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2. J Cell Biochem 2019;120:5747-55. [DOI: 10.1002/jcb.27861] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
89 Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M. Circulating EZH2-positive T cells are decreased in multiple sclerosis patients. J Neuroinflammation 2018;15:296. [PMID: 30367633 DOI: 10.1186/s12974-018-1336-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
90 Yu F, Xie C, Jiang C, Sun J, Feng H, Li C, Huang X. MiR-92a inhibits fibroblast-like synoviocyte proliferation and migration in rheumatoid arthritis by targeting AKT2. J Biosci 2018;43:911-9. [DOI: 10.1007/s12038-018-9803-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
91 Li G, Wang C, Wang Y, Xu B, Zhang W. LINC00312 represses proliferation and metastasis of colorectal cancer cells by regulation of miR-21. J Cell Mol Med 2018;22:5565-72. [PMID: 30134003 DOI: 10.1111/jcmm.13830] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
92 Kai D, Yannian L, Yitian C, Dinghao G, Xin Z, Wu J. Circular RNA HIPK3 promotes gallbladder cancer cell growth by sponging microRNA-124. Biochem Biophys Res Commun 2018;503:863-9. [PMID: 29928876 DOI: 10.1016/j.bbrc.2018.06.088] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 10.8] [Reference Citation Analysis]
93 Cao J, Qiu J, Wang X, Lu Z, Wang D, Feng H, Li X, Liu Q, Pan H, Han X, Wei J, Liu S, Wang L. Identification of microRNA-124 in regulation of Hepatocellular carcinoma through BIRC3 and the NF-κB pathway. J Cancer 2018;9:3006-15. [PMID: 30210622 DOI: 10.7150/jca.25956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
94 Chen WH, Cai MY, Zhang JX, Wang FW, Tang LQ, Liao YJ, Jin XH, Wang CY, Guo L, Jiang YG, Ren CP, Mai HQ, Zeng MS, Kung HF, Qian CN, Xie D. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1. Oncogene 2018;37:6243-58. [PMID: 30013189 DOI: 10.1038/s41388-018-0351-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
95 Yang C, Gao X, Ye J, Ding J, Liu Y, Liu H, Li X, Zhang Y, Zhou J, Huang W, Fang F, Ling Y. The interaction between DNA methylation and long non-coding RNA during the onset of puberty in goats. Reprod Domest Anim 2018;53:1287-97. [PMID: 29981216 DOI: 10.1111/rda.13246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
96 Li X, Zhao Z, Li M, Liu M, Bahena A, Zhang Y, Zhang Y, Nambiar C, Liu G. Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p. Biomedicine & Pharmacotherapy 2018;103:473-81. [DOI: 10.1016/j.biopha.2018.03.121] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
97 Liu F, Hu H, Zhao J, Zhang Z, Ai X, Tang L, Xie L. miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer. Biomed Rep 2018;9:147-55. [PMID: 30013778 DOI: 10.3892/br.2018.1113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
98 Sa KD, Zhang X, Li XF, Gu ZP, Yang AG, Zhang R, Li JP, Sun JY. A miR-124/ITGA3 axis contributes to colorectal cancer metastasis by regulating anoikis susceptibility. Biochem Biophys Res Commun 2018;501:758-64. [PMID: 29758195 DOI: 10.1016/j.bbrc.2018.05.062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
99 Erstad DJ, Fuchs BC, Tanabe KK. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy. Cancer 2018;124:3084-104. [DOI: 10.1002/cncr.31257] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
100 Barbier J, Chen X, Sanchez G, Cai M, Helsmoortel M, Higuchi T, Giraud P, Contreras X, Yuan G, Feng Z, Nait-Saidi R, Deas O, Bluy L, Judde JG, Rouquier S, Ritchie W, Sakamoto S, Xie D, Kiernan R. An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression. Cell Res 2018;28:556-71. [PMID: 29563539 DOI: 10.1038/s41422-018-0016-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
101 Cardin SE, Borchert GM. Viral MicroRNAs, Host MicroRNAs Regulating Viruses, and Bacterial MicroRNA-Like RNAs. Methods Mol Biol 2017;1617:39-56. [PMID: 28540675 DOI: 10.1007/978-1-4939-7046-9_3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
102 Pan Y, Wu A, Xu F, Chen C, Jiang L, Jin R. Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer. Oncol Lett 2018;15:7450-8. [PMID: 29731896 DOI: 10.3892/ol.2018.8194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
103 Zhang Q, Li X, Li X, Li X, Chen Z. LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells. J Cell Biochem 2018;119:4447-57. [PMID: 29219208 DOI: 10.1002/jcb.26537] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 10.2] [Reference Citation Analysis]
104 Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol 2018;15:137-51. [PMID: 29317776 DOI: 10.1038/nrgastro.2017.169] [Cited by in Crossref: 247] [Cited by in F6Publishing: 262] [Article Influence: 49.4] [Reference Citation Analysis]
105 Xiao S, Wang R, Wu X, Liu W, Ma S. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53. DNA Cell Biol 2018;37:117-25. [PMID: 29412778 DOI: 10.1089/dna.2017.3941] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis]
106 He RQ, Yang X, Liang L, Chen G, Ma J. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. Oncol Lett 2018;15:5517-32. [PMID: 29552191 DOI: 10.3892/ol.2018.8045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
107 Chen G, Shi Y, Liu M, Sun J. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death Dis 2018;9:175. [PMID: 29415990 DOI: 10.1038/s41419-017-0204-3] [Cited by in Crossref: 177] [Cited by in F6Publishing: 195] [Article Influence: 35.4] [Reference Citation Analysis]
108 Xie RT, Cong XL, Zhong XM, Luo P, Yang HQ, Lu GX, Luo P, Chang ZY, Sun R, Wu TM, Lv ZW, Fu D, Ma YS. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2018;15:4571-7. [PMID: 29541227 DOI: 10.3892/ol.2018.7892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
109 Wang G, Liu H, Wei Z, Jia H, Liu Y, Liu J. Systematic analysis of the molecular mechanism of microRNA-124 in hepatoblastoma cells. Oncol Lett 2017;14:7161-70. [PMID: 29344147 DOI: 10.3892/ol.2017.7131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
110 Pajares MA, Pérez-Sala D. Mammalian Sulfur Amino Acid Metabolism: A Nexus Between Redox Regulation, Nutrition, Epigenetics, and Detoxification. Antioxid Redox Signal 2018;29:408-52. [PMID: 29186975 DOI: 10.1089/ars.2017.7237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
111 Wu GQ, Chai KQ, Zhu XM, Jiang H, Wang X, Xue Q, Zheng AH, Zhou HY, Chen Y, Chen XC, Xiao JY, Ying XH, Wang FW, Rui T, Liao YJ, Xie D, Lu LQ, Huang DS. Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1. Oncotarget 2016;7:26535-50. [PMID: 27049834 DOI: 10.18632/oncotarget.8532] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
112 Ma X, Wang L, Cao Z, Hu H, Lu Z, Xu-monette Z, Young K, Li Y. Physiological and Pathological Functions of Mammalian MicroRNAs. Comprehensive Toxicology 2018. [DOI: 10.1016/b978-0-12-801238-3.95612-5] [Reference Citation Analysis]
113 Pérez-sala D, Martínez-costa ÓH, Aragón JJ, Pajares MA. Alterations in Nucleocytoplasmic Localization of the Methionine Cycle Induced by Oxidative Stress During Liver Disease. The Liver 2018. [DOI: 10.1016/b978-0-12-803951-9.00003-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Matsubara M, Bissell MJ. Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context. Oncotarget 2016;7:31602-22. [PMID: 27203208 DOI: 10.18632/oncotarget.9395] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
115 Huang T, Zhou Y, Zhang J, Wong CC, Li W, Kwan JSH, Yang R, Chan AKY, Dong Y, Wu F, Zhang B, Cheung AHK, Wu WKK, Cheng ASL, Yu J, Wong N, Kang W, To KF. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. Oncogene 2018;37:1159-74. [PMID: 29234151 DOI: 10.1038/s41388-017-0029-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
116 Li H, Guan S, Lu Y, Wang F. MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4. Biomedicine & Pharmacotherapy 2017;96:208-14. [DOI: 10.1016/j.biopha.2017.09.079] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
117 Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, Romani M. MicroRNA in Glioblastoma: An Overview. Int J Genomics 2017;2017:7639084. [PMID: 29234674 DOI: 10.1155/2017/7639084] [Cited by in Crossref: 74] [Cited by in F6Publishing: 87] [Article Influence: 12.3] [Reference Citation Analysis]
118 Naaman H, Rall G, Matullo C, Veksler-Lublinsky I, Shemer-Avni Y, Gopas J. MiRNA-124 is a link between measles virus persistent infection and cell division of human neuroblastoma cells. PLoS One 2017;12:e0187077. [PMID: 29073265 DOI: 10.1371/journal.pone.0187077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
119 Jin K, Li T, Sánchez-Duffhues G, Zhou F, Zhang L. Involvement of inflammation and its related microRNAs in hepatocellular carcinoma. Oncotarget 2017;8:22145-65. [PMID: 27888618 DOI: 10.18632/oncotarget.13530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
120 Bhatia S, Monkman J, Toh AKL, Nagaraj SH, Thompson EW. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochem J 2017;474:3269-306. [PMID: 28931648 DOI: 10.1042/BCJ20160782] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
121 Zhang Y, Wei C, Guo CC, Bi RX, Xie J, Guan DH, Yang CH, Jiang YH. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis. Oncotarget 2017;8:107237-57. [PMID: 29291025 DOI: 10.18632/oncotarget.20883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
122 Chen Z, Wang X, Liu R, Chen L, Yi J, Qi B, Shuang Z, Liu M, Li X, Li S, Tang H. KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells. Oncotarget 2017;8:17712-25. [PMID: 27487123 DOI: 10.18632/oncotarget.10832] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
123 Wang H, Zhang TT, Jin S, Liu H, Zhang X, Ruan CG, Wu DP, Han Y, Wang XQ. Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome. Clin Epigenetics 2017;9:91. [PMID: 28861128 DOI: 10.1186/s13148-017-0388-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
124 Cao J, Han X, Qi X, Jin X, Li X. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p. Int J Oncol 2017;51:1115-23. [PMID: 28902349 DOI: 10.3892/ijo.2017.4110] [Cited by in Crossref: 68] [Cited by in F6Publishing: 76] [Article Influence: 11.3] [Reference Citation Analysis]
125 Zhao X, Wang L, Chen G. Joint Covariate Detection on Expression Profiles for Identifying MicroRNAs Related to Venous Metastasis in Hepatocellular Carcinoma. Sci Rep 2017;7:5349. [PMID: 28706271 DOI: 10.1038/s41598-017-05776-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
126 Xu Y, Ge K, Lu J, Huang J, Wei W, Huang Q. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2). Biomed Pharmacother 2017;93:334-43. [PMID: 28651234 DOI: 10.1016/j.biopha.2017.06.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
127 Zhang J, Fan J, Zhou C, Qi Y. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA. BMC Gastroenterol 2017;17:81. [PMID: 28637446 DOI: 10.1186/s12876-017-0637-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
128 Yi X, Guo J, Guo J, Sun S, Yang P, Wang J, Li Y, Xie L, Cai J, Wang Z. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion. Sci Rep 2017;7:3568. [PMID: 28620234 DOI: 10.1038/s41598-017-03362-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
129 Grisard E, Nicoloso MS. Following MicroRNAs Through the Cancer Metastatic Cascade. Int Rev Cell Mol Biol 2017;333:173-228. [PMID: 28729025 DOI: 10.1016/bs.ircmb.2017.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
130 Yan KS, Lin CY, Liao TW, Peng CM, Lee SC, Liu YJ, Chan WP, Chou RH. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe? Int J Mol Sci 2017;18:E1172. [PMID: 28561778 DOI: 10.3390/ijms18061172] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 7.7] [Reference Citation Analysis]
131 Yang F, Lu J, Yu Y, Gong Y. Epithelial to mesenchymal transition in Cyclosporine A-induced rat gingival overgrowth. Arch Oral Biol 2017;81:48-55. [PMID: 28472720 DOI: 10.1016/j.archoralbio.2017.04.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
132 Tian F, Chen J, Zheng S, Li D, Zhao X, Jiang P, Li J, Wang S. miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis. BMC Cancer 2017;17:175. [PMID: 28270130 DOI: 10.1186/s12885-017-3166-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
133 Ye W, Chen C, Gao Y, Zheng ZS, Xu Y, Yun M, Weng HW, Xie D, Ye S, Zhang JX. Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity. Cell Death Dis 2017;8:e2581. [PMID: 28151475 DOI: 10.1038/cddis.2017.13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
134 Faluyi OO, Eng L, Qiu X, Che J, Zhang Q, Cheng D, Ying N, Tse A, Kuang Q, Dodbiba L, Renouf DJ, Marsh S, Savas S, Mackay HJ, Knox JJ, Darling GE, Wong RK, Xu W, Azad AK, Liu G. Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival. Cancer Med. 2017;6:361-373. [PMID: 28074552 DOI: 10.1002/cam4.989] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
135 Wu L, Bai X, Xie Y, Yang Z, Yang X, Lin J, Zhu C, Wang A, Zhang H, Miao R, Wu Y, Robson SC, Zhao Y, Sang X, Zhao H. MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development. Hepatol Res 2017;47:80-94. [PMID: 27138942 DOI: 10.1111/hepr.12737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
136 Zimmermann A. Mechanisms of Invasion and Metastasis: Cell Migration and Chemotaxis. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_181] [Reference Citation Analysis]
137 Chang TT, Thakar D, Weaver VM. Force-dependent breaching of the basement membrane. Matrix Biol 2017;57-58:178-89. [PMID: 28025167 DOI: 10.1016/j.matbio.2016.12.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
138 Liu X, Zhao J, Liu Q, Xiong X, Zhang Z, Jiao Y, Li X, Liu B, Li Y, Lu Y. MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. Sci Rep. 2016;6:37170. [PMID: 27845424 DOI: 10.1038/srep37170] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
139 Wang Y, Chen L, Wu Z, Wang M, Jin F, Wang N, Hu X, Liu Z, Zhang CY, Zen K, Chen J, Liang H, Zhang Y, Chen X. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL. BMC Cancer. 2016;16:826. [PMID: 27842510 DOI: 10.1186/s12885-016-2862-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
140 Wong W, Hardikar AA, Joglekar MV. Generation of Human Islet Progenitor Cells via Epithelial-to-Mesenchymal Transition. In: A. Hardikar A, editor. Pancreatic Islet Biology. Cham: Springer International Publishing; 2016. pp. 217-40. [DOI: 10.1007/978-3-319-45307-1_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Huang Y, Tao Y, Hu K, Lin F, Li X, Feng T, Wang ZM. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma. Tumour Biol 2016;37:14903-14. [PMID: 27644248 DOI: 10.1007/s13277-016-5392-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
142 Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Oncotarget 2015;6:37808-23. [PMID: 26498692 DOI: 10.18632/oncotarget.5676] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
143 Zhou X, Ren Y, Kong L, Cai G, Sun S, Song W, Wang Y, Jin R, Qi L, Mei M, Wang X, Kang C, Li M, Zhang L. Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC. Oncotarget 2015;6:33720-32. [PMID: 26378043 DOI: 10.18632/oncotarget.5606] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
144 Wang X, Liu D, Zhou K, Wang B, Liu Q, Deng F, Li Q, Ma Y. Expression of Wnt11 and Rock2 in esophageal squamous cell carcinoma by activation of the WNT/PCP pathway and its clinical significance. Pathol Res Pract 2016;212:880-5. [PMID: 27628667 DOI: 10.1016/j.prp.2016.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
145 Yue Q, Zhang Y, Li X, He L, Hu Y, Wang X, Xu X, Shen Y, Zhang H. MiR-124 suppresses the chemotactic migration of rat mesenchymal stem cells toward HGF by downregulating Wnt/β-catenin signaling. Eur J Cell Biol 2016;95:342-53. [PMID: 27377850 DOI: 10.1016/j.ejcb.2016.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
146 Kim YH, Lee WK, Lee EB, Son JW, Kim DS, Park JY. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer. Clin Lung Cancer 2017;18:e13-20. [PMID: 27444357 DOI: 10.1016/j.cllc.2016.06.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
147 Yang S, Pei Y, Li X, Zhao S, Zhu M, Zhao A. miR-124 attenuates Japanese encephalitis virus replication by targeting DNM2. Virol J 2016;13:105. [PMID: 27329300 DOI: 10.1186/s12985-016-0562-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
148 Huang J, Yang J, Lei Y, Gao H, Wei T, Luo L, Zhang F, Chen H, Zeng Q, Guo L. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma. Oncogenesis 2016;5:e229. [PMID: 27239961 DOI: 10.1038/oncsis.2016.22] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
149 Chen GS, Zhou N, Li JQ, Li T, Zhang ZQ, Si ZZ. Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells. Onco Targets Ther 2016;9:3067-76. [PMID: 27313460 DOI: 10.2147/OTT.S96861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
150 Hawa Z, Haque I, Ghosh A, Banerjee S, Harris L, Banerjee SK. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Int J Mol Sci 2016;17:E809. [PMID: 27240340 DOI: 10.3390/ijms17060809] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
151 Italiano A. Role of the EZH2 histone methyltransferase as a therapeutic target in cancer. Pharmacol Ther 2016;165:26-31. [PMID: 27179746 DOI: 10.1016/j.pharmthera.2016.05.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
152 Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol 2016;49:5-32. [PMID: 27175518 DOI: 10.3892/ijo.2016.3503] [Cited by in Crossref: 127] [Cited by in F6Publishing: 145] [Article Influence: 18.1] [Reference Citation Analysis]
153 Wang N, Wang Q, Shen D, Sun X, Cao X, Wu D. Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial-mesenchymal transition. Onco Targets Ther. 2016;9:2035-2047. [PMID: 27103830 DOI: 10.2147/ott.s92378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
154 Li C, Cai M, Jiang L, Mai S, Chen J, Wang F, Liao Y, Chen W, Jin X, Pei X, Guan X, Zeng M, Xie D. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. CARCIN 2016;37:557-66. [DOI: 10.1093/carcin/bgw036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
155 Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
156 Louten J, Beach M, Palermino K, Weeks M, Holenstein G. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights. 2015;10:25-52. [PMID: 26819546 DOI: 10.4137/bmi.s29512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
157 Cai S, Chen R, Li X, Cai Y, Ye Z, Li S, Li J, Huang H, Peng S, Wang J, Tao Y, Huang H, Wen X, Mo J, Deng Z, Wang J, Zhang Y, Gao X, Wen X. Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway. Oncotarget 2015;6:3904-17. [PMID: 25714010 DOI: 10.18632/oncotarget.2880] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 7.7] [Reference Citation Analysis]
158 Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel Insights into the Roles of Rho Kinase in Cancer. Arch Immunol Ther Exp (Warsz) 2016;64:259-78. [PMID: 26725045 DOI: 10.1007/s00005-015-0382-6] [Cited by in Crossref: 126] [Cited by in F6Publishing: 102] [Article Influence: 18.0] [Reference Citation Analysis]
159 Kaur S, Lotsari-Salomaa JE, Seppänen-Kaijansinkko R, Peltomäki P. MicroRNA Methylation in Colorectal Cancer. Adv Exp Med Biol 2016;937:109-22. [PMID: 27573897 DOI: 10.1007/978-3-319-42059-2_6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
160 Zimmermann A. Mechanisms of Invasion and Metastasis: Cell Migration and Chemotaxis. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_181-1] [Reference Citation Analysis]
161 Li Y, Sarkar FH. Targeting MicroRNAs: Molecular Basis of Cancer Prevention. Molecular Targets and Strategies in Cancer Prevention 2016. [DOI: 10.1007/978-3-319-31254-5_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
162 Kumar S, Stokes JA, Singh UP, Bishnupuri KS, Mishra MK. Enhancer of Zeste Homology 2 (Ezh2), an Epigenetic Regulator: A Possibility for Prostate Cancer Treatment. Epigenetic Advancements in Cancer 2016. [DOI: 10.1007/978-3-319-24951-3_10] [Reference Citation Analysis]
163 Suzuki H, Maruyama R, Yamamoto E, Niinuma T, Kai M. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer. Advances in Experimental Medicine and Biology 2016. [DOI: 10.1007/978-981-10-1498-7_4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
164 Yang F, Lv LZ, Cai QC, Jiang Y. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. World J Gastroenterol 2015; 21(47): 13268-13276 [PMID: 26715809 DOI: 10.3748/wjg.v21.i47.13268] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
165 Wu GQ, Wang X, Zhou HY, Chai KQ, Xue Q, Zheng AH, Zhu XM, Xiao JY, Ying XH, Wang FW, Rui T, Xu LY, Zhang YK, Liao YJ, Xie D, Lu LQ, Huang DS. Evidence for transcriptional interference in a dual-luciferase reporter system. Sci Rep 2015;5:17675. [PMID: 26620302 DOI: 10.1038/srep17675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
166 Jiang L, Lin T, Xu C, Hu S, Pan Y, Jin R. miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer. J Cell Mol Med 2016;20:313-22. [PMID: 26612211 DOI: 10.1111/jcmm.12724] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
167 Long J, Jiang C, Liu B, Fang S, Kuang M. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumor Biol 2016;37:5821-8. [DOI: 10.1007/s13277-015-4427-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
168 Martínez-Fernández M, Rubio C, Segovia C, López-Calderón FF, Dueñas M, Paramio JM. EZH2 in Bladder Cancer, a Promising Therapeutic Target. Int J Mol Sci 2015;16:27107-32. [PMID: 26580594 DOI: 10.3390/ijms161126000] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
169 Qiu Z, Guo W, Wang Q, Chen Z, Huang S, Zhao F, Yao M, Zhao Y, He X. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells. Gastroenterology 2015;149:1587-1598.e11. [PMID: 26248089 DOI: 10.1053/j.gastro.2015.07.050] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 6.5] [Reference Citation Analysis]
170 Yu X, Li Z. The role of miRNAs in cutaneous squamous cell carcinoma. J Cell Mol Med 2016;20:3-9. [PMID: 26508273 DOI: 10.1111/jcmm.12649] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
171 Tripathi A, Goswami K, Sanan-Mishra N. Role of bioinformatics in establishing microRNAs as modulators of abiotic stress responses: the new revolution. Front Physiol 2015;6:286. [PMID: 26578966 DOI: 10.3389/fphys.2015.00286] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
172 Chen SP, Liu BX, Xu J, Pei XF, Liao YJ, Yuan F, Zheng F. MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets. BMC Cancer. 2015;15:706. [PMID: 26471185 DOI: 10.1186/s12885-015-1738-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
173 Gao XR, Wang HP, Zhang SL, Wang MX, Zhu ZS. Pri-miR-124 rs531564 polymorphism and colorectal cancer risk. Sci Rep 2015;5:14818. [PMID: 26423518 DOI: 10.1038/srep14818] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
174 Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Diagn Pathol 2015;10:178. [PMID: 26415857 DOI: 10.1186/s13000-015-0391-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
175 Bonet F, Dueñas Á, López-Sánchez C, García-Martínez V, Aránega AE, Franco D. MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation. Dev Dyn 2015;244:1259-75. [PMID: 26198058 DOI: 10.1002/dvdy.24309] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
176 Joensuu EI, Nieminen TT, Lotsari JE, Pavicic W, Abdel-rahman WM, Peltomäki P. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer: Methyltransferases in Colon Cancer. Genes Chromosomes Cancer 2015;54:776-87. [DOI: 10.1002/gcc.22289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
177 Anwar SL, Lehmann U. MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas. J Clin Med. 2015;4:1631-1650. [PMID: 26295264 DOI: 10.3390/jcm4081631] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
178 Lv YF, Yan GN, Meng G, Zhang X, Guo QN. Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma. Sci Rep 2015;5:12999. [PMID: 26265454 DOI: 10.1038/srep12999] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
179 Drakaki A, Hatziapostolou M, Polytarchou C, Vorvis C, Poultsides GA, Souglakos J, Georgoulias V, Iliopoulos D. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer 2015;15:542. [PMID: 26206264 DOI: 10.1186/s12885-015-1562-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
180 Chen SM, Chou WC, Hu LY, Hsiung CN, Chu HW, Huang YL, Hsu HM, Yu JC, Shen CY. The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity. PLoS One 2015;10:e0128472. [PMID: 26115122 DOI: 10.1371/journal.pone.0128472] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
181 Suzhi Z, Liang T, Yuexia P, Lucy L, Xiaoting H, Yuan Z, Qin W. Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells: GAP JUNCTIONS ENHANCE THE EFFECT OF MICRORNA-124-3p. J Cell Physiol 2015;230:2476-88. [DOI: 10.1002/jcp.24982] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
182 Li J, Yang S, Yan W, Yang J, Qin YJ, Lin XL, Xie RY, Wang SC, Jin W, Gao F. MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition. Lab Invest. 2015;95:1056-1070. [PMID: 26098000 DOI: 10.1038/labinvest.2015.76] [Cited by in Crossref: 69] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
183 Zhou L, Liu F, Wang X, Ouyang G. The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci 2015;5:32. [PMID: 26146543 DOI: 10.1186/s13578-015-0028-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
184 Wang Y, Huang C, Chintagari NR, Xi D, Weng T, Liu L. miR-124 regulates fetal pulmonary epithelial cell maturation. Am J Physiol Lung Cell Mol Physiol. 2015;309:L400-L413. [PMID: 26071557 DOI: 10.1152/ajplung.00356.2014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
185 Wang T, Chen T, Niu H, Li C, Xu C, Li Y, Huang R, Zhao J, Wu S. MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1. Int J Mol Med. 2015;36:93-102. [PMID: 25999024 DOI: 10.3892/ijmm.2015.2216] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
186 Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update. World J Clin Cases 2015; 3(5): 393-404 [PMID: 25984514 DOI: 10.12998/wjcc.v3.i5.393] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
187 Dong LL, Chen LM, Wang WM, Zhang LM. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Diagn Pathol 2015;10:45. [PMID: 25924779 DOI: 10.1186/s13000-015-0257-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
188 Zoni E, van der Pluijm G, Gray PC, Kruithof-de Julio M. Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT. J Oncol 2015;2015:198967. [PMID: 25883651 DOI: 10.1155/2015/198967] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
189 Huang W, Gao F, Li K, Wang W, Lai YR, Tang SH, Yang DH. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma. World J Gastroenterol 2015; 21(10): 3055-3065 [PMID: 25780306 DOI: 10.3748/wjg.v21.i10.3055] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
190 Li M, Zhou W, Yuan R, Chen L, Liu T, Huang D, Hao L, Xie Y, Shao J. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling. FEBS Lett 2015;589:1018-25. [PMID: 25771860 DOI: 10.1016/j.febslet.2015.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
191 Li Z, Yu X, Shen J, Chan MT, Wu WK. MicroRNA in intervertebral disc degeneration. Cell Prolif 2015;48:278-83. [PMID: 25736871 DOI: 10.1111/cpr.12180] [Cited by in Crossref: 117] [Cited by in F6Publishing: 124] [Article Influence: 14.6] [Reference Citation Analysis]
192 Chen G, Lu L, Liu C, Shan L, Yuan D. MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma. PLoS One 2015;10:e0117714. [PMID: 25739101 DOI: 10.1371/journal.pone.0117714] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
193 Feng T, Xu D, Tu C, Li W, Ning Y, Ding J, Wang S, Yuan L, Xu N, Qian K, Wang Y, Qi C. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumour Biol 2015;36:5987-97. [PMID: 25731732 DOI: 10.1007/s13277-015-3275-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
194 Wang H, Yan C, Shi X, Zheng J, Deng L, Yang L, Yu F, Yang Y, Shao Y. MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells. FEBS Lett 2015;589:805-11. [PMID: 25728273 DOI: 10.1016/j.febslet.2015.02.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
195 Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie Y, Li S, Tang G, Tang H, He X. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem. 2014;392:153-159. [PMID: 24658854 DOI: 10.1007/s11010-014-2028-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
196 Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP, Wu PH, Wu L, Bian XW, Guan XY, Zeng YX, Yuan YF, Kung HF, Xie D. Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet. 2015;11:e1004873. [PMID: 25693145 DOI: 10.1371/journal.pgen.1004873] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 9.4] [Reference Citation Analysis]
197 Neo WH, Yap K, Lee SH, Looi LS, Khandelia P, Neo SX, Makeyev EV, Su IH. MicroRNA miR-124 controls the choice between neuronal and astrocyte differentiation by fine-tuning Ezh2 expression. J Biol Chem 2014;289:20788-801. [PMID: 24878960 DOI: 10.1074/jbc.M113.525493] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 10.4] [Reference Citation Analysis]
198 Yan SY, Chen MM, Li GM, Wang YQ, Fan JG. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. Tumour Biol. 2015;36:4747-4755. [PMID: 25647261 DOI: 10.1007/s13277-015-3124-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
199 Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T, Zhang F, Hill SM, Liu W, Maiti SN, Cooper L, Azencot R, Lopez-Berestein G, Rodriguez-Aguayo C, Roopaimoole R, Pecot CV, Sood AK, Mukherjee S, Gray JW, Mills GB, Ram PT. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. Oncogene 2016;35:691-701. [PMID: 25639871 DOI: 10.1038/onc.2014.469] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
200 George J, Patel T. Noncoding RNA as therapeutic targets for hepatocellular carcinoma. Semin Liver Dis 2015;35:63-74. [PMID: 25632936 DOI: 10.1055/s-0034-1397350] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
201 Lian JY, Tuo BG. Role of non-coding RNAs in development and progression of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(3): 396-403 [DOI: 10.11569/wcjd.v23.i3.396] [Reference Citation Analysis]
202 Huang LL, Zhang Y, Zhang JX, He LJ, Lai YR, Liao YJ, Tian XP, Deng HX, Liang YJ, Kung HF, Xie D, Zhu SL. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma. Tumour Biol 2015;36:4405-15. [PMID: 25596704 DOI: 10.1007/s13277-015-3080-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
203 Wang L, Lu M, Yi M, Chen L, Shen J, Li Z, Li L, Yang Y, Zhang J, Li Y. Caffeic acid attenuates the autocrine IL-6 in hepatocellular carcinoma via the epigenetic silencing of the NF-κB-IL-6-STAT-3 feedback loop. RSC Adv 2015;5:52952-7. [DOI: 10.1039/c5ra05878c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
204 Li KK, Huang K, Kondengaden S, Wooten J, Reyhanfard H, Qing Z, Zhai BC, Wang PG. Histone Methyltransferase Inhibitors for Cancer Therapy. Epigenetic Technological Applications 2015. [DOI: 10.1016/b978-0-12-801080-8.00017-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
205 Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev 2015;81:62-74. [PMID: 25450260 DOI: 10.1016/j.addr.2014.10.029] [Cited by in Crossref: 122] [Cited by in F6Publishing: 125] [Article Influence: 15.3] [Reference Citation Analysis]
206 Morishita A, Masaki T. miRNA in hepatocellular carcinoma. Hepatol Res 2015;45:128-41. [PMID: 25040738 DOI: 10.1111/hepr.12386] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 9.4] [Reference Citation Analysis]
207 Han G, Wang Y, Bi W, Jia J, Wang W. MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. Exp Ther Med 2015;9:679-84. [PMID: 25667613 DOI: 10.3892/etm.2014.2161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
208 Abrantes JL, Tornatore TF, Pelizzaro-Rocha KJ, de Jesus MB, Cartaxo RT, Milani R, Ferreira-Halder CV. Crosstalk between kinases, phosphatases and miRNAs in cancer. Biochimie 2014;107 Pt B:167-87. [PMID: 25230087 DOI: 10.1016/j.biochi.2014.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
209 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
210 Zhang JX, Mai SJ, Huang XX, Wang FW, Liao YJ, Lin MC, Kung HF, Zeng YX, Xie D. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Ann Oncol. 2014;25:2196-2204. [PMID: 25193986 DOI: 10.1093/annonc/mdu439] [Cited by in Crossref: 75] [Cited by in F6Publishing: 85] [Article Influence: 8.3] [Reference Citation Analysis]
211 Harries LW. MicroRNAs as Mediators of the Ageing Process. Genes (Basel). 2014;5:656-670. [PMID: 25140888 DOI: 10.3390/genes5030656] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 7.7] [Reference Citation Analysis]
212 Han LL, Lv Y, Guo H, Ruan ZP, Nan KJ. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 2014; 20(30): 10249-10261 [PMID: 25132742 DOI: 10.3748/wjg.v20.i30.10249] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
213 Chen T, Wang XY, Li C, Xu SJ. Downregulation of microRNA-124 predicts poor prognosis in glioma patients. Neurol Sci 2015;36:131-5. [PMID: 25112530 DOI: 10.1007/s10072-014-1895-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
214 Zhu Z, Zhang X, Wang G, Zheng H. Role of MicroRNAs in Hepatocellular Carcinoma. Hepat Mon 2014;14:e18672. [PMID: 25337143 DOI: 10.5812/hepatmon.18672] [Cited by in Crossref: 34] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
215 Wang T, Gu J, Li Y. Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method. BMC Bioinformatics 2014;15:255. [PMID: 25069957 DOI: 10.1186/1471-2105-15-255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
216 Mao J, Zhang M, Zhong M, Zhang Y, Lv K. MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion. Mol Cell Biochem 2014;396:117-28. [PMID: 25055875 DOI: 10.1007/s11010-014-2148-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
217 Bian EB, Li J, He XJ, Zong G, Jiang T, Li J, Zhao B. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2. Expert Opin Ther Targets 2014;18:1197-206. [PMID: 25046371 DOI: 10.1517/14728222.2014.941807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
218 Yamaguchi H, Hung MC. Regulation and Role of EZH2 in Cancer. Cancer Res Treat 2014;46:209-22. [PMID: 25038756 DOI: 10.4143/crt.2014.46.3.209] [Cited by in Crossref: 189] [Cited by in F6Publishing: 198] [Article Influence: 21.0] [Reference Citation Analysis]
219 Shen K, Mao R, Ma L, Li Y, Qiu Y, Cui D, Le V, Yin P, Ni L, Liu J. Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. FEBS J. 2014;281:3609-3624. [PMID: 24942287 DOI: 10.1111/febs.12880] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
220 Chu R, Mo G, Duan Z, Huang M, Chang J, Li X, Liu P. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Cell Commun Signal. 2014;12:45. [PMID: 25012758 DOI: 10.1186/s12964-014-0045-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
221 Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS One. 2014;9:e101330. [PMID: 24992599 DOI: 10.1371/journal.pone.0101330] [Cited by in Crossref: 77] [Cited by in F6Publishing: 87] [Article Influence: 8.6] [Reference Citation Analysis]
222 Ma C, Li Y, Li M, Deng G, Wu X, Zeng J, Hao X, Wang X, Liu J, Cho WC, Liu X, Wang Y. microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection. Mol Immunol 2014;62:150-8. [PMID: 24995397 DOI: 10.1016/j.molimm.2014.06.014] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
223 Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol 2014; 20(24): 7894-7913 [PMID: 24976726 DOI: 10.3748/wjg.v20.i24.7894] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 66] [Article Influence: 6.7] [Reference Citation Analysis]
224 Geng S, Zhang X, Chen J, Liu X, Zhang H, Xu X, Ma Y, Li B, Zhang Y, Bi Z, Yang C. The tumor suppressor role of miR-124 in osteosarcoma. PLoS One 2014;9:e91566. [PMID: 24971902 DOI: 10.1371/journal.pone.0091566] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
225 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell 2014;5:673-91. [PMID: 24916440 DOI: 10.1007/s13238-014-0065-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 115] [Article Influence: 11.3] [Reference Citation Analysis]
226 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 2014;5:673-691. [PMID: 24916440 DOI: 10.1007/s13238- 014-0065-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
227 Park SY, Kim H, Yoon S, Bae JA, Choi SY, Jung YD, Kim KK. KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis. Mol Ther 2014;22:1653-64. [PMID: 24909917 DOI: 10.1038/mt.2014.105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
228 Varela MA, Roberts TC, Wood MJ. Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurotherapeutics 2013;10:621-31. [PMID: 24068583 DOI: 10.1007/s13311-013-0212-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
229 Yao W, Guo G, Zhang Q, Fan L, Wu N, Bo Y. The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells. Virology 2014;458-459:69-82. [DOI: 10.1016/j.virol.2014.04.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
230 Lee CH, Kim JH, Lee SW. The role of microRNAs in hepatitis C virus replication and related liver diseases. J Microbiol. 2014;52:445-451. [PMID: 24871972 DOI: 10.1007/s12275-014-4267-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
231 Tan W, Li Y, Lim SG, Tan TM. miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 5962-5972 [PMID: 24876719 DOI: 10.3748/wjg.v20.i20.5962] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
232 Wang C, Tong X, Yang F. Bioengineered 3D Brain Tumor Model To Elucidate the Effects of Matrix Stiffness on Glioblastoma Cell Behavior Using PEG-Based Hydrogels. Mol Pharmaceutics 2014;11:2115-25. [DOI: 10.1021/mp5000828] [Cited by in Crossref: 165] [Cited by in F6Publishing: 167] [Article Influence: 18.3] [Reference Citation Analysis]
233 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178-196. [PMID: 24556840 DOI: 10.1038/nrm3758] [Cited by in Crossref: 4715] [Cited by in F6Publishing: 5038] [Article Influence: 523.9] [Reference Citation Analysis]
234 Wilson JA, Sagan SM. Hepatitis C virus and human miR-122: insights from the bench to the clinic. Curr Opin Virol. 2014;7:11-18. [PMID: 24721497 DOI: 10.1016/j.coviro.2014.03.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
235 Ma C, Li Y, Zeng J, Wu X, Liu X, Wang Y. Mycobacterium bovis BCG triggered MyD88 induces miR-124 feedback negatively regulates immune response in alveolar epithelial cells. PLoS One 2014;9:e92419. [PMID: 24705038 DOI: 10.1371/journal.pone.0092419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
236 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int. 2014;2014:486407. [PMID: 24800233 DOI: 10.1155/2014/486407] [Cited by in Crossref: 39] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
237 Dong YW, Wang R, Cai QQ, Qi B, Wu W, Zhang YH, Wu XZ. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. J Hepatol 2014;60:792-801. [PMID: 24333181 DOI: 10.1016/j.jhep.2013.12.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
238 Valencia-Quintana R, Sánchez-Alarcón J, Tenorio-Arvide MG, Deng Y, Montiel-González JM, Gómez-Arroyo S, Villalobos-Pietrini R, Cortés-Eslava J, Flores-Márquez AR, Arenas-Huertero F. The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol 2014;5:102. [PMID: 24672518 DOI: 10.3389/fmicb.2014.00102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
239 Kałużna EM. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection? Rev Med Virol 2014;24:169-85. [PMID: 24591085 DOI: 10.1002/rmv.1785] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
240 Liu J, Cai M, Chen J, Liao Y, Mai S, Li Y, Huang X, Liu Y, Zhang J, Kung H, Zeng Y, Zhou F, Xie D. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients. European Journal of Cancer 2014;50:840-51. [DOI: 10.1016/j.ejca.2013.11.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
241 Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 2014;1845:255-265. [PMID: 24569228 DOI: 10.1016/j.bbcan.2014.02.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 102] [Article Influence: 4.4] [Reference Citation Analysis]
242 Wei JH, Cao JZ, Zhang D, Liao B, Zhong WM, Lu J, Zhao HW, Zhang JX, Tong ZT, Fan S, Liang CZ, Liao YB, Pang J, Wu RH, Fang Y, Chen ZH, Li B, Xie D, Chen W, Luo JH. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo. Br J Cancer. 2014;110:1767-1777. [PMID: 24504366 DOI: 10.1038/bjc.2014.52] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
243 Gupta P, Liu B, Wu JQ, Soriano V, Vispo E, Carroll AP, Goldie BJ, Cairns MJ, Saksena NK. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection. Virology. 2014;450-451:336-349. [PMID: 24503097 DOI: 10.1016/j.virol.2013.12.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
244 Huang S, Xie Y, Yang P, Chen P, Zhang L. HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells. PLoS One. 2014;9:e81730. [PMID: 24416131 DOI: 10.1371/journal.pone.0081730] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
245 Yuwh H, Szemy D, Chocs W, Yipsp. Targeting Immune System Through Targeting miRNA for Cancer Therapy. MicroRNA Targeted Cancer Therapy 2014. [DOI: 10.1007/978-3-319-05134-5_15] [Reference Citation Analysis]
246 Frau M, Feo CF, Feo F, Pascale RM. New insights on the role of epigenetic alterations in hepatocellular carcinoma. J Hepatocell Carcinoma 2014;1:65-83. [PMID: 27508177 DOI: 10.2147/JHC.S44506] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Gu X, Meng S, Liu S, Jia C, Fang Y, Li S, Fu C, Song Q, Lin L, Wang X. miR-124 represses ROCK1 expression to promote neurite elongation through activation of the PI3K/Akt signal pathway. J Mol Neurosci. 2014;52:156-165. [PMID: 24338057 DOI: 10.1007/s12031-013-0190-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
248 Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, Guo J, Xi S, Gao J, Lin X, Kong Y, Xu X, Tang H, Xie X, Liu M. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer 2013;12:163. [PMID: 24330780 DOI: 10.1186/1476-4598-12-163] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 8.2] [Reference Citation Analysis]
249 Suzuki H, Maruyama R, Yamamoto E, Kai M. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet. 2013;4:258. [PMID: 24348513 DOI: 10.3389/fgene.2013.00258] [Cited by in Crossref: 105] [Cited by in F6Publishing: 115] [Article Influence: 10.5] [Reference Citation Analysis]
250 Zhang H, Wang Q, Zhao Q, Di W. MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res. 2013;6:84. [PMID: 24279510 DOI: 10.1186/1757-2215-6-84] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 9.3] [Reference Citation Analysis]
251 Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Shibata C, Koike K. The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. J Gastroenterol. 2014;49:173-184. [PMID: 24258409 DOI: 10.1007/s00535-013-0909-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
252 Gu J, Xuan Z. Inferring the perturbed microRNA regulatory networks in cancer using hierarchical gene co-expression signatures. PLoS One 2013;8:e81032. [PMID: 24278370 DOI: 10.1371/journal.pone.0081032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
253 Cheng Q, Yi B, Wang A, Jiang X. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 2013;6:1675-84. [PMID: 24273410 DOI: 10.2147/OTT.S52730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
254 Lu Y, Yue X, Cui Y, Zhang J, Wang K. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Biochem Biophys Res Commun. 2013;441:873-879. [PMID: 24211205 DOI: 10.1016/j.bbrc.2013.10.157] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
255 Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu X, Wu J, Zhu Y, Zheng X, Luo J, Xie L. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. J Transl Med 2013;11:276. [PMID: 24180482 DOI: 10.1186/1479-5876-11-276] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 8.6] [Reference Citation Analysis]
256 D’amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer. Cancer Letters 2013;341:46-55. [DOI: 10.1016/j.canlet.2012.11.054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
257 Guo J, Xia B, Meng F, Lou G. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Biochemical and Biophysical Research Communications 2013;441:357-63. [DOI: 10.1016/j.bbrc.2013.10.052] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
258 Long L, Huang G, Zhu H, Guo Y, Liu Y, Huo J. Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med. 2013;11:275. [PMID: 24171926 DOI: 10.1186/1479-5876-11-275] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
259 Guo J, Xia B, Meng F, Lou G. miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol. 2014;35:1557-1564. [PMID: 24127040 DOI: 10.1007/s13277-013-1215-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
260 Chen XX, Lin J, Qian J, Qian W, Yang J, Ma JC, Deng ZQ, Xie D, An C, Tang CY, Qian Z. Dysregulation of miR-124-1 predicts favorable prognosis in acute myeloid leukemia. Clin Biochem 2014;47:63-6. [PMID: 24135052 DOI: 10.1016/j.clinbiochem.2013.09.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
261 Lee Y, Kim HJ, Park CK, Kim Y, Lee H, Kim J, Kim H. MicroRNA-124 regulates osteoclast differentiation. Bone 2013;56:383-9. [DOI: 10.1016/j.bone.2013.07.007] [Cited by in Crossref: 107] [Cited by in F6Publishing: 105] [Article Influence: 10.7] [Reference Citation Analysis]
262 Yuan Y, Shen Y, Xue L, Fan H. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. PLoS One 2013;8:e73604. [PMID: 24039995 DOI: 10.1371/journal.pone.0073604] [Cited by in Crossref: 79] [Cited by in F6Publishing: 91] [Article Influence: 7.9] [Reference Citation Analysis]
263 Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene. 2014;33:4069-4076. [PMID: 24013226 DOI: 10.1038/onc.2013.369] [Cited by in Crossref: 115] [Cited by in F6Publishing: 130] [Article Influence: 11.5] [Reference Citation Analysis]
264 Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: Role of microRNA. World J Gastroenterol 2013; 19(33): 5439-5445 [PMID: 24023486 DOI: 10.3748/wjg.v19.i33.5439] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
265 Yan D, Skogerbø G. microRNAs and Cancer. microRNAs in Toxicology and Medicine 2013. [DOI: 10.1002/9781118695999.ch7] [Reference Citation Analysis]
266 Yang S, Liu X, Li X, Sun S, Sun F, Fan B, Zhao S. MicroRNA-124 reduces caveolar density by targeting caveolin-1 in porcine kidney epithelial PK15 cells. Mol Cell Biochem 2013;384:213-9. [PMID: 24000013 DOI: 10.1007/s11010-013-1800-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
267 Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, Cstoth I, Dernies T, Toussaint L, Leclercq N, Sculier JP; European Lung Cancer Working Party. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 2013;82:340-5. [PMID: 24007627 DOI: 10.1016/j.lungcan.2013.07.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
268 Wang R, Zhao N, Li S, Fang JH, Chen MX, Yang J, Jia WH, Yuan Y, Zhuang SM. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 2013;58:642-53. [PMID: 23468064 DOI: 10.1002/hep.26373] [Cited by in Crossref: 162] [Cited by in F6Publishing: 174] [Article Influence: 16.2] [Reference Citation Analysis]
269 Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 2013;280:4531-8. [PMID: 23815091 DOI: 10.1111/febs.12417] [Cited by in Crossref: 109] [Cited by in F6Publishing: 125] [Article Influence: 10.9] [Reference Citation Analysis]
270 Liu C. The role of microRNAs in tumors. Arch Pharm Res. 2013;36:1169-1177. [PMID: 23881700 DOI: 10.1007/s12272-013-0213-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
271 An L, Liu Y, Wu A, Guan Y. microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS One 2013;8:e69478. [PMID: 23936026 DOI: 10.1371/journal.pone.0069478] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 8.1] [Reference Citation Analysis]
272 Crea F, Fornaro L, Bocci G, Sun L, Farrar WL, Falcone A, Danesi R. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis. Cancer Metastasis Rev 2012;31:753-61. [PMID: 22711031 DOI: 10.1007/s10555-012-9387-3] [Cited by in Crossref: 122] [Cited by in F6Publishing: 131] [Article Influence: 12.2] [Reference Citation Analysis]
273 Li K, Liu C, Zhou B, Bi L, Huang H, Lin T, Xu K. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells. Int J Mol Sci 2013;14:11981-93. [PMID: 23739676 DOI: 10.3390/ijms140611981] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
274 Jazirehi AR, Torres-collado AX, Nazarian R. Research Highlights: Highlights from the latest articles in epigenomics. Epigenomics 2013;5:251-254. [DOI: 10.2217/epi.13.23] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
275 Zhang J, Wei J, Lu J, Tong Z, Liao B, Yu B, Zheng F, Huang X, Chen Z, Fang Y, Li B, Chen W, Xie D, Luo J. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Carcinogenesis 2013;34:2401-8. [PMID: 23722651 DOI: 10.1093/carcin/bgt187] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
276 Qiu S, Huang D, Yin D, Li F, Li X, Kung HF, Peng Y. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Biochim Biophys Acta. 2013;1832:1697-1707. [PMID: 23707559 DOI: 10.1016/j.bbadis.2013.05.015] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 7.5] [Reference Citation Analysis]
277 Chai S, Ma S. Clinical implications of microRNAs in liver cancer stem cells. Chin J Cancer 2013;32:419-26. [PMID: 23668930 DOI: 10.5732/cjc.013.10038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
278 Au SL, Ng IO, Wong CM. Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins. Front Med 2013;7:231-41. [PMID: 23620257 DOI: 10.1007/s11684-013-0253-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
279 Bahi A, Dreyer JL. Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption. Eur J Neurosci 2013;38:2328-37. [PMID: 23601049 DOI: 10.1111/ejn.12228] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
280 Pinto R, Pilato B, Ottini L, Lambo R, Simone G, Paradiso A, Tommasi S. Different methylation and microRNA expression pattern in male and female familial breast cancer. J Cell Physiol 2013;228:1264-9. [PMID: 23160909 DOI: 10.1002/jcp.24281] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
281 Bhetwal BP, An C, Baker SA, Lyon KL, Perrino BA. Impaired contractile responses and altered expression and phosphorylation of Ca(2+) sensitization proteins in gastric antrum smooth muscles from ob/ob mice. J Muscle Res Cell Motil. 2013;34:137-149. [PMID: 23576331 DOI: 10.1007/s10974-013-9341-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
282 Thibault PA, Wilson JA. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host. Pharmacol Res 2013;75:48-59. [PMID: 23541631 DOI: 10.1016/j.phrs.2013.03.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
283 Wang S, Zhu Y, He H, Liu J, Xu L, Zhang H, Liu H, Liu W, Liu Y, Pan D, Chen L, Wu Q, Xu J, Gu J. Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2. Cancer Sci 2013;104:750-9. [PMID: 23421437 DOI: 10.1111/cas.12132] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
284 Calvisi DF, Frau M, Tomasi ML, Feo F, Pascale RM. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison. Biochim Biophys Acta 2012;1826:215-37. [PMID: 23393659 DOI: 10.1016/j.bbcan.2012.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
285 Yu HW, Sze DM, Cho WC. MicroRNAs Involved in Anti-Tumour Immunity. Int J Mol Sci. 2013;14:5587-5607. [PMID: 23478435 DOI: 10.3390/ijms14035587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
286 Shi JW, Liu W, Zhang TT, Wang SC, Lin XL, Li J, Jia JS, Sheng HF, Yao ZF, Zhao WT, Zhao ZL, Xie RY, Yang S, Gao F, Fan QR, Zhang MY, Yue M, Yuan J, Gu WW, Yao KT, Xiao D. The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation. Cell Cycle 2013;12:1119-27. [PMID: 23466707 DOI: 10.4161/cc.24164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
287 Lamouille S, Subramanyam D, Blelloch R, Derynck R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol. 2013;25:200-207. [PMID: 23434068 DOI: 10.1016/j.ceb.2013.01.008] [Cited by in Crossref: 204] [Cited by in F6Publishing: 183] [Article Influence: 20.4] [Reference Citation Analysis]
288 Hilakivi-Clarke L, de Assis S, Warri A. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia 2013;18:25-42. [PMID: 23392570 DOI: 10.1007/s10911-013-9274-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
289 Sun J, Lu H, Wang X, Jin H. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal 2013;2013:924206. [PMID: 23431261 DOI: 10.1155/2013/924206] [Cited by in Crossref: 40] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
290 Fan DN, Tsang FH, Tam AH, Au SL, Wong CC, Wei L, Lee JM, He X, Ng IO, Wong CM. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Hepatology 2013;57:637-47. [PMID: 22991213 DOI: 10.1002/hep.26083] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 7.5] [Reference Citation Analysis]
291 Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K, Luo J, Chen Z, Meng Z, Liu L. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene. 2014;33:514-524. [PMID: 23334332 DOI: 10.1038/onc.2012.598] [Cited by in Crossref: 157] [Cited by in F6Publishing: 175] [Article Influence: 15.7] [Reference Citation Analysis]
292 Au SL, Ng IO, Wong C. Epigenetic Regulation of EZH2 and Its Targeted MicroRNAs. Epigenetics and Cancer 2013. [DOI: 10.1007/978-94-007-6612-9_3] [Reference Citation Analysis]
293 Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR, Zhao Q. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013;34:713-22. [PMID: 23250910 DOI: 10.1093/carcin/bgs383] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 13.2] [Reference Citation Analysis]
294 Zhang JX, Qian D, Wang FW, Liao DZ, Wei JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, Zeng YX, Xie D, Mai SJ. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Lett 2013;329:91-8. [PMID: 23142283 DOI: 10.1016/j.canlet.2012.10.033] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
295 Benetatos L, Voulgaris E, Vartholomatos G, Hatzimichael E. Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome. Int J Cancer. 2013;133:267-274. [PMID: 23001607 DOI: 10.1002/ijc.27859] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
296 Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Biochem Biophys Res Commun. 2012;428:525-531. [PMID: 23068095 DOI: 10.1016/j.bbrc.2012.10.039] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
297 Wang L, Ho J, Glackin C, Martins-Green M. Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl Oncol 2012;5:344-55. [PMID: 23066443 DOI: 10.1593/tlo.12190] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
298 Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012;19:723-730. [PMID: 22975591 DOI: 10.1038/cgt.2012.58] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
299 Rath N, Olson MF. Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep. 2012;13:900-908. [PMID: 22964758 DOI: 10.1038/embor.2012.127] [Cited by in Crossref: 231] [Cited by in F6Publishing: 239] [Article Influence: 21.0] [Reference Citation Analysis]
300 Lang Q, Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Res Commun. 2012;426:247-252. [PMID: 22940133 DOI: 10.1016/j.bbrc.2012.08.075] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 9.1] [Reference Citation Analysis]
301 Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L, Zhang Y, Zhou B, Zhou ZG, Sun XF. Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis. 2013;28:183-189. [PMID: 22885837 DOI: 10.1007/s00384-012-1550-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
302 Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG, Zeng ZY, Cheng HZ. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer. 2012;11:51. [PMID: 22867052 DOI: 10.1186/1476-4598-11-51] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 7.3] [Reference Citation Analysis]
303 Zeng B, Li Z, Chen R, Guo N, Zhou J, Zhou Q, Lin Q, Cheng D, Liao Q, Zheng L. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3. FEBS Lett. 2012;586:3271-3278. [PMID: 22819820 DOI: 10.1016/j.febslet.2012.06.049] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
304 Thorns C, Kuba J, Bernard V, Senft A, Szymczak S, Feller AC, Bernd H. Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch 2012;460:371-7. [DOI: 10.1007/s00428-012-1215-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
305 Huang N, Lin J, Ruan J, Su N, Qing R, Liu F, He B, Lv C, Zheng D, Luo R. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett. 2012;586:884-891. [PMID: 22449976 DOI: 10.1016/j.febslet.2012.02.017] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
306 Xia H, Cheung WKC, Ng SS, Jiang X, Jiang S, Sze J, Leung GKK, Lu G, Chan DTM, Bian XW, Kung HF, Poon WS, Lin MC. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 2012;287:9962-71. [PMID: 22253443 DOI: 10.1074/jbc.M111.332627] [Cited by in Crossref: 135] [Cited by in F6Publishing: 143] [Article Influence: 12.3] [Reference Citation Analysis]
307 Lv XB, Jiao Y, Qing Y, Hu H, Cui X, Lin T, Song E, Yu F. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer 2011;30:821-30. [PMID: 22085528 DOI: 10.5732/cjc.011.10289] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]